Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | October 1, 2013 |
| Target | Cydan |
| Sector | Life Science |
| Investor(s) | Bay City Capital |
| Deal Type | Venture |
FILTER BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 72 of 75 |
| Sector: Life Science | 52 of 54 |
| Type: Venture | 47 of 49 |
| State: Massachusetts | 10 of 10 |
| Country: United States | 69 of 72 |
| Year: 2013 | 8 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-01 |
Civitas Therapeutics
Chelsea, Massachusetts, United States Civitas Therapeutics, Inc. is a biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically proven ARCUS® dry powder pulmonary delivery platform. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-10-04 |
PharmAkea
San Diego, California, United States PharmAkea is a biopharmaceutical company and is a developer of high-quality, small molecule drug candidates against protein targets involved in fibroproliferative diseases. PharmAkea was founded in 2012 and is based in San Diego, California. |
Buy | - |
